anh-usa

The FDA under the leadership of Acting Commissioner Kyle Diamantas is poised to eliminate access to compounded natural desiccated thyroid. For patients who depend on individualized thyroid treatment, the consequences could be devastating.

Vaccine choice only works when government recommendations, evidence, and potential conflicts are communicated clearly and consistently with sufficient transparency. Recent and past comments by HHS Secretary Kennedy don’t meet these standards and likely exacerbate public confusion and polarization.

Listen to the audio version of this article:

...

FDA’s proposed GRAS reform could deliver long-overdue transparency to what’s in America’s food supply—but unless the agency modernizes its approach to natural ingredients, consumers may pay the price in reduced innovation, choice, and access.

A sweeping new Executive Order could significantly reshape childhood vaccine policy by prioritizing individualized recommendations, parental choice, flexible scheduling, and new scrutiny of vaccine safety.

Listen to the audio version of this article:

THE TOPLINE

The executive order would...

A one-month bridge may keep full-spectrum hemp products legal long enough for Congress to act. Action Alert!

THE TOPLINE

A Senate proposal would delay the federal hemp-prod...